ConductScience.org, home

Paper33708784

Therapeutic Insights in Chronic Kidney Disease Progression.

Shabaka A and 2 others. Front Med (Lausanne), 2021. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic Insights in Chronic Kidney Disease Progression. Papers, record 33708784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33708784

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic Insights in Chronic Kidney Disease Progression.
PubMed
Journal
Front Med (Lausanne)
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
4.29
iCite
Revised in PubMed
2021-03-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shabaka AAmir
2Cases-Corona CClara
3Fernandez-Juarez GGema

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119608703Bicarbonate supplementation slows progression of CKD and improves nutritional status.J Am Soc Nephrol2009https://conductscience.org/library/papers/19608703PubMed
226774608Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.Lancet Diabetes Endocrinol2016https://conductscience.org/library/papers/26774608PubMed
320413961Debate: CON position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?Am J Nephrol2010https://conductscience.org/library/papers/20413961PubMed
424107852Bicarbonate therapy for prevention of chronic kidney disease progression.Kidney Int2014https://conductscience.org/library/papers/24107852PubMed
522436957Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.JAMA2012https://conductscience.org/library/papers/22436957PubMed
623121378Cardiorenal end points in a trial of aliskiren for type 2 diabetes.N Engl J Med2012https://conductscience.org/library/papers/23121378PubMed
717460140Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes.J Am Soc Nephrol2007https://conductscience.org/library/papers/17460140PubMed
821541658Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.Cell Tissue Res2012https://conductscience.org/library/papers/21541658PubMed
925441440Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation study.Am J Kidney Dis2014https://conductscience.org/library/papers/25441440PubMed
1029992892Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship?Curr Cardiol Rev2019https://conductscience.org/library/papers/29992892PubMed
1127299675Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.N Engl J Med2016https://conductscience.org/library/papers/27299675PubMed
1232970396Dapagliflozin in Patients with Chronic Kidney Disease.N Engl J Med2020https://conductscience.org/library/papers/32970396PubMed
1330361325DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.J Am Soc Nephrol2018https://conductscience.org/library/papers/30361325PubMed
1422490878Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.Clin J Am Soc Nephrol2012https://conductscience.org/library/papers/22490878PubMed
1523608655Endothelin, kidney disease, and hypertension.Hypertension2013https://conductscience.org/library/papers/23608655PubMed
1627733283
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
Lancet2016https://conductscience.org/library/papers/27733283PubMed
1728284376The Tubulointerstitial Pathophysiology of Progressive Kidney Disease.Adv Chronic Kidney Dis2017https://conductscience.org/library/papers/28284376PubMed
1816123474Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study.Diabetes Care2005https://conductscience.org/library/papers/16123474PubMed
1915516696Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.N Engl J Med2004https://conductscience.org/library/papers/15516696PubMed
2024904085Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes.J Am Soc Nephrol2014https://conductscience.org/library/papers/24904085PubMed

See all 76 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
42656977Modulating Renal Fibrosis: The Emerging Role of Hepatocyte Growth Factor.Int J Nephrol2026https://conductscience.org/library/papers/42656977PubMed
42179848Efficacy and safety of finerenone in chronic kidney disease stages 3-4 in diabetic and non-diabetic patients with an eGFR 20-60 mL/min: a prospective cohort study.Front Nephrol2026https://conductscience.org/library/papers/42179848PubMed
42133559Potential Mechanisms of Sodium-Glucose Cotransporter 2 Inhibitors in Regulating Cardiac and Renal Fibrosis.Cardiorenal Med2026https://conductscience.org/library/papers/42133559PubMed
41588213Blood pressure and renal function decline in apparently healthy adults: the tehran lipid and glucose study.J Hum Hypertens2026https://conductscience.org/library/papers/41588213PubMed
41516982Translational Lifestyle Medicine Approaches to Cardiovascular-Kidney-Metabolic Syndrome.Healthcare (Basel)2025https://conductscience.org/library/papers/41516982PubMed
41348383The role of amino acid signaling in pathogenesis of chronic kidney disease.Mol Cell Biochem2026https://conductscience.org/library/papers/41348383PubMed
40872522Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and GLP-1 RAs.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40872522PubMed
40607119Targeted co-delivery of IL-10 and catalase for cooperative therapeutic effect on acute kidney injury.Bioact Mater2025https://conductscience.org/library/papers/40607119PubMed
40474975Bupropion decreases plasma levels of asymmetric dimethylarginine and ameliorates renal injury by modulation of Ddah1, Oatp4c1, Oct2, and Mate1 in rats with adenine-induced chronic renal injury.Front Pharmacol2025https://conductscience.org/library/papers/40474975PubMed
40454508Beyond Traditional Silos: An Integrated Framework Leveraging Novel Pathways for Reducing Cardio-renal Risk in Type 2 Diabetes.Curr Diabetes Rev2026https://conductscience.org/library/papers/40454508PubMed
40027896Advances in kidney disease: pathogenesis and therapeutic targets.Front Med (Lausanne)2025https://conductscience.org/library/papers/40027896PubMed
39848232Personalized Care in CKD: Moving Beyond Traditional Biomarkers.Nephron2025https://conductscience.org/library/papers/39848232PubMed
39525849Dysregulation of the 3β-hydroxysteroid dehydrogenase type 2 enzyme and steroid hormone biosynthesis in chronic kidney disease.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/39525849PubMed
39450151An In Situ Sustained-Release Chitosan Hydrogel to Attenuate Renal Fibrosis by Retaining Klotho Expression.Biomater Res2024https://conductscience.org/library/papers/39450151PubMed
39196533Renal Protective Effect of Umbelliferone on Acute Kidney Injury in Rats via Alteration of HO-1/Nrf2 and NF-κB Signaling Pathway.Dokl Biochem Biophys2024https://conductscience.org/library/papers/39196533PubMed
38835403Chronic Kidney Disease in Brazil: Current Status and Recommended Improvements.Kidney Dis (Basel)2024https://conductscience.org/library/papers/38835403PubMed
38255158Adiponectin C1q/Tumor Necrosis Factor-Related Protein 13 (CTRP13) Protects against Renal Inflammation and Fibrosis in Obstructive Nephropathy.Biomedicines2023https://conductscience.org/library/papers/38255158PubMed
38196830Impact of Sodium-Glucose Cotransporter-2 Inhibitors in the Management of Chronic Kidney Disease: A Middle East and Africa Perspective.Int J Nephrol Renovasc Dis2024https://conductscience.org/library/papers/38196830PubMed
38186336Serum vitamin C levels and their correlation with chronic kidney disease in adults: a nationwide study.Ren Fail2024https://conductscience.org/library/papers/38186336PubMed
38169578Beneficial effects of physical exercise on the osteo-renal Klotho-FGF-23 axis in Chronic Kidney Disease: A systematic review with meta-analysis.Int J Med Sci2024https://conductscience.org/library/papers/38169578PubMed

See all 43 cited byDownload CSV of cited by

Genes20

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGT183PubTator's text mininghttps://conductscience.org/library/genes/183NCBI Gene
AGTR1185PubTator's text mininghttps://conductscience.org/library/genes/185NCBI Gene
AP2B1163PubTator's text mininghttps://conductscience.org/library/genes/163NCBI Gene
APOA4337PubTator's text mininghttps://conductscience.org/library/genes/337NCBI Gene
CCN21490PubTator's text mininghttps://conductscience.org/library/genes/1490NCBI Gene
CST31471PubTator's text mininghttps://conductscience.org/library/genes/1471NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
DKK327122PubTator's text mininghttps://conductscience.org/library/genes/27122NCBI Gene
EDN11906PubTator's text mininghttps://conductscience.org/library/genes/1906NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
HAVCR126762PubTator's text mininghttps://conductscience.org/library/genes/26762NCBI Gene
HLA-G3135PubTator's text mininghttps://conductscience.org/library/genes/3135NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
LCN23934PubTator's text mininghttps://conductscience.org/library/genes/3934NCBI Gene
LGALS33958PubTator's text mininghttps://conductscience.org/library/genes/3958NCBI Gene
NFE2L24780PubTator's text mininghttps://conductscience.org/library/genes/4780NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene
SLC5A26524PubTator's text mininghttps://conductscience.org/library/genes/6524NCBI Gene
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040NCBI Gene
TNFRSF1A7132PubTator's text mininghttps://conductscience.org/library/genes/7132NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33708784

GET https://conductscience.org/api/papers/v1/33708784/references?page=2